Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Alexander

Showing results (891-900 of 1,212) with videos related to

Pageof 122
Sort By:
European Heart Journal|November 16, 2022
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillationZiad Hijazi, Alexander P Benz, Johan Lindbäck, et al.
Frontiers in Pharmacology|February 7, 2019
Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial CellsRosalia Grande, Melania Dovizio, Simone Marcone, et al.
Journal of the American Heart Association|December 9, 2020
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial FibrillationZiad Hijazi, Lars Wallentin, Johan Lindbäck, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Cardiovascular Research|August 6, 2021
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillationTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
American Heart Journal|October 12, 2024
The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and designRichard P Whitlock, Patrick M McCarthy, Marc W Gerdisch, et al.
Neuropharmacology|June 7, 2008
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory painMaulik D Jhaveri, Denise Richardson, Ian Robinson, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|June 29, 2011
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trialRajendra H Mehta, T Bruce Ferguson, Renato D Lopes, et al.
The American Journal of Cardiology|August 30, 2008
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)James M Yau, John H Alexander, Gail Hafley, et al.
Pageof 122

Showing results (891-900 of 1,212) with videos related to

Sort By:
Pageof 122
European Heart Journal|November 16, 2022
Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillationZiad Hijazi, Alexander P Benz, Johan Lindbäck, et al.
Frontiers in Pharmacology|February 7, 2019
Platelet-Derived Microparticles From Obese Individuals: Characterization of Number, Size, Proteomics, and Crosstalk With Cancer and Endothelial CellsRosalia Grande, Melania Dovizio, Simone Marcone, et al.
Journal of the American Heart Association|December 9, 2020
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial FibrillationZiad Hijazi, Lars Wallentin, Johan Lindbäck, et al.
Journal of the American Heart Association|June 20, 2015
Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomesKenneth W Mahaffey, Rebecca Hager, Daniel Wojdyla, et al.
Cardiovascular Research|August 6, 2021
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillationTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.
American Heart Journal|October 12, 2024
The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and designRichard P Whitlock, Patrick M McCarthy, Marc W Gerdisch, et al.
Neuropharmacology|June 7, 2008
Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory painMaulik D Jhaveri, Denise Richardson, Ian Robinson, et al.
American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.
Circulation|June 29, 2011
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trialRajendra H Mehta, T Bruce Ferguson, Renato D Lopes, et al.
The American Journal of Cardiology|August 30, 2008
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)James M Yau, John H Alexander, Gail Hafley, et al.
Pageof 122